# Baxdela

NDC: 70842-102
Generic name: delafloxacin meglumine
Labeler / Manufacturer: Melinta Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20170619

FDA application: NDA208611

## Active ingredients

- DELAFLOXACIN MEGLUMINE: 300 mg/10.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70842-102"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70842-102
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fb77637a-88d9-4aea-958f-e270030ce30d